| 51 |
15324515 | Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes. | 2004 Aug |
2 |
| 52 |
12502670 | Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. | 2003 Jan |
1 |
| 53 |
12852706 | Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea. | 2003 Mar |
2 |
| 54 |
12380632 | Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study. | 2002 Sep |
1 |
| 55 |
12406033 | Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy. | 2002 Nov |
1 |
| 56 |
11252980 | [Type 2 diabetes: what therapeutic strategy?]. | 2001 Feb 17 |
1 |
| 57 |
11525086 | [The thiazolidinedione derivates: a new class of oral blood glucose lowering agents]. | 2001 Aug 11 |
1 |
| 58 |
11703422 | Miglitol combined with metformin improves glycaemic control in type 2 diabetes. | 2001 Oct |
1 |
| 59 |
11712407 | [Rosiglitazone(BRL-49653)]. | 2001 Nov |
1 |
| 60 |
11192132 | Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group. | 2000 Dec |
1 |
| 61 |
11220991 | Pioglitazone. | 2000 Nov |
1 |
| 62 |
10333901 | First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization. | 1999 Jan |
1 |
| 63 |
10630028 | [The combination of insulin and metformin in obese patients with type-2 diabetes mellitus]. | 1999 Nov 15 |
1 |
| 64 |
9839093 | Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes. | 1998 Dec |
1 |
| 65 |
9972673 | Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable? | 1998 Dec |
1 |
| 66 |
9021342 | The KID Study. III: Impact of inpatient rehabilitation on the metabolic control of type I and type II diabetics--a one-year follow-up. | 1996 |
1 |
| 67 |
7843470 | One year comparative trial of metformin and glipizide in type 2 diabetes mellitus. | 1994 Jul-Aug |
1 |
| 68 |
1936476 | The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM). | 1991 May |
1 |
| 69 |
1936482 | Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide. | 1991 May |
1 |
| 70 |
2060439 | Double-blind evaluation of efficacy and tolerability of metformin in NIDDM. | 1991 Apr |
2 |
| 71 |
2647992 | The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy. | 1989 Feb |
1 |
| 72 |
2682123 | [Body mass index, blood lactate and therapeutic effectiveness of metformin in type II diabetes mellitus]. | 1989 Apr-Jun |
1 |
| 73 |
6403102 | Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes. | 1983 Mar 12 |
1 |